Samsara BioCapital, LLC ALMS — ALUMIS INC

Ownership history in Samsara BioCapital, LLC  ·  6 quarters on record

AI Ownership Summary

Samsara BioCapital, LLC reported ALUMIS INC (ALMS) in 6 quarterly 13F filings from 2024 Q3 through 2025 Q4. Peak portfolio weight reached 6.71% in 2024 Q3. The latest visible filing shows ALMS at 5.80% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings.

What this ALMS ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was Samsara BioCapital, LLC's position in ALUMIS INC, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2025 Q4

ALMS was reported at 5.80% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
6.71% in 2024 Q3

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2024 Q3 to 2025 Q4

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

ALMS stock page Samsara BioCapital, LLC fund profile Samsara BioCapital, LLC full holdings
How Samsara BioCapital, LLC held ALMS — position size vs. price
% of Fund (quarterly)    ALMS price (quarter-end, indexed to 100)    SPY (indexed to 100)    QQQ (indexed to 100)
📋 Quarterly Holdings History 6 quarters  ▾
Quarter Action Sold % After 3M Timing Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2025 Q4 ADDED — — — 5,756,984 +955,614 +19.9% 5.80% $56.2M 2026-02-14 (Est.) $26.54
2025 Q3 UNCHANGED — — — 4,801,370 — 0% 2.50% $19.2M 2025-11-14 $5.52
2025 Q2 ADDED — — — 4,801,370 +1,534,872 +47.0% 2.95% $14.4M 2025-08-14 $4.39
2025 Q1 UNCHANGED — — — 3,266,498 — 0% 3.58% $20.1M 2025-05-15 $5.35
2024 Q4 UNCHANGED — — — 3,266,498 — 0% 3.52% $25.7M 2025-02-14 $5.21
2024 Q3 INITIATED — — — 3,266,498 — — 6.71% $34.9M 2024-11-14 $9.41

🏢 Other funds also holding ALMS

As of 2026 Q1 — sorted by position size

Trium Capital LLP 3Y 2.97% SmartHarvest Portfolios, LLC 0.09% Inscription Capital, LLC 3Y 0.06% China Universal Asset Management Co., Ltd. 3Y 0.04% PROFUND ADVISORS LLC 3Y 7Y 0.01% True Wealth Design, LLC 3Y 0.0% Farther Finance Advisors, LLC 0.0% Versant Capital Management, Inc 3Y 7Y 0.0% GAMMA Investing LLC 0.0% Sterling Capital Management LLC 3Y 7Y 0.0%

FAQ About Samsara BioCapital, LLC and ALMS

These are the practical questions this page is built to answer before you even open the full history table.

How long has Samsara BioCapital, LLC reported owning ALMS?

Samsara BioCapital, LLC reported ALMS across 6 quarterly 13F filings, from 2024 Q3 through 2025 Q4.

What was the largest reported ALMS position in Samsara BioCapital, LLC's portfolio?

The largest reported portfolio weight for ALMS was 6.71% in 2024 Q3.

What is the latest reported ALMS position on this page?

The most recent filing on this page is 2025 Q4, when Samsara BioCapital, LLC reported 5,756,984 shares, equal to 5.80% of portfolio, with an estimated market value of $56.2M.

What does the chart on this ALMS ownership page compare?

The chart compares Samsara BioCapital, LLC's quarterly ALMS portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

← Back to Samsara BioCapital, LLC Holdings